APA

Currier M. A., Eshun F. K., Sholl A., Chernoguz A., Crawford K., Divanovic S., Boon L., Goins W. F., Frischer J. S., Collins M. H., Leddon J. L., Baird W. H., Haseley A., Streby K. A., Wang P., Hendrickson B. W., Brekken R. A., Kaur B., Hildeman D. & Cripe T. P. (20140429). VEGF blockade enables oncolytic cancer virotherapy in part by modulating intratumoral myeloid cells. : Molecular therapy : the journal of the American Society of Gene Therapy.

Chicago

Currier Mark A, Eshun Francis K, Sholl Allyson, Chernoguz Artur, Crawford Kelly, Divanovic Senad, Boon Louis, Goins William F, Frischer Jason S, Collins Margaret H, Leddon Jennifer L, Baird William H, Haseley Amy, Streby Keri A, Wang Pin-Yi, Hendrickson Brett W, Brekken Rolf A, Kaur Balveen, Hildeman David and Cripe Timothy P. 20140429. VEGF blockade enables oncolytic cancer virotherapy in part by modulating intratumoral myeloid cells. : Molecular therapy : the journal of the American Society of Gene Therapy.

Harvard

Currier M. A., Eshun F. K., Sholl A., Chernoguz A., Crawford K., Divanovic S., Boon L., Goins W. F., Frischer J. S., Collins M. H., Leddon J. L., Baird W. H., Haseley A., Streby K. A., Wang P., Hendrickson B. W., Brekken R. A., Kaur B., Hildeman D. and Cripe T. P. (20140429). VEGF blockade enables oncolytic cancer virotherapy in part by modulating intratumoral myeloid cells. : Molecular therapy : the journal of the American Society of Gene Therapy.

MLA

Currier Mark A, Eshun Francis K, Sholl Allyson, Chernoguz Artur, Crawford Kelly, Divanovic Senad, Boon Louis, Goins William F, Frischer Jason S, Collins Margaret H, Leddon Jennifer L, Baird William H, Haseley Amy, Streby Keri A, Wang Pin-Yi, Hendrickson Brett W, Brekken Rolf A, Kaur Balveen, Hildeman David and Cripe Timothy P. VEGF blockade enables oncolytic cancer virotherapy in part by modulating intratumoral myeloid cells. : Molecular therapy : the journal of the American Society of Gene Therapy. 20140429.